Intermediate Reports
Press Releases

Eran Taus, the CEO of Novolog, has announced that he will be stepping down from his position after six years

,
April 18, 2023
April 19, 2023
Eran Taus, the CEO of Novolog, has announced that he will be stepping down from his position after six years in office. He informed the company's management and board of directors of his decision today, and his last day in the position will be on October 17, 2023. Taus joined Novolog in 2017 and has since led the company through a significant period of growth, including a number of acquisitions and expansion that have turned Novolog into a leading health services group with around 1,000 employees. The company currently operates through three divisions: logistics, health services, and digital. Reflecting on his tenure, Taus said: "Over the last six years, Novolog has become the leading healthcare group in Israel. We have grown in all areas, made strategic acquisitions, and implemented a plan for continued growth. It has been an honor to lead Novolog alongside its dedicated employees and managers, and I want to thank the company's board of directors for their support." The board of directors expressed their gratitude for Taus's contributions to the company and its many achievements during his tenure. Under his leadership, Novolog expanded into new areas, experienced impressive growth in sales and profits, and saw an increase in its market value. The board has established a search committee, headed by chairman Rami Dar and two other members, to find Taus's successor as CEO.

Press Releases

June 30, 2024
March 6, 2024

The publication date for the financial statements of 2023 is March 26th, 2024, with a conference meeting scheduled for the same date at 1:00 PM

March 10, 2022
December 21, 2021

Preliminary medical inquiries, without human contact

Novolog Group’s Digital Division, together with the startup Kahun, are currently launching “Symptomi”

March 10, 2022
September 25, 2021

International Pharmacist’s Day

An opportunity to show appreciation to pharmacists for their efforts and to spotlight their contribution to the healthcare system.

Intermediate Reports

January 28, 2025
January 19, 2025

Update regarding the launching of a new ERP system

January 8, 2025
November 19, 2024

In November 19, 2024, the company announced distribution of dividend in the amount of NIS 10 million

January 8, 2025
January 8, 2025

Company's Extraordinary and Annual General Meeting of Shareholders has been postponed and will now be held on Thursday, February 15, 2025